Elacestrant (RAD1901) is a selective and orally bioavailable estrogen receptor (ER) degrader with IC50 of 48 and 870 nM for ERα and ERβ, respectively. References: Garner F, et al. RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models. Anticancer Drugs. 2015 Oct;26(9):948-56.

纯度：≥98%

CAS：722533-56-4